Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens by fernando | Jan 6, 2026 | Media Coverage
Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer by fernando | Dec 18, 2025 | Media Coverage
Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic by Cartography | Oct 3, 2025 | Media Coverage
Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team by Cartography | Sep 3, 2025 | Media Coverage
Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors by Cartography | Oct 29, 2024 | Media Coverage
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs by Cartography | May 28, 2024 | Media Coverage
